User profiles for M. Hammarlund-Udenaes

Margareta Hammarlund-Udenaes

Uppsala university
Verified email at farmbio.uu.se
Cited by 10090

[HTML][HTML] On the rate and extent of drug delivery to the brain

M Hammarlund-Udenaes, M Fridén, S Syvänen… - Pharmaceutical …, 2008 - Springer
To define and differentiate relevant aspects of blood–brain barrier transport and distribution
in order to aid research methodology in brain drug delivery. Pharmacokinetic parameters …

Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer's disease

…, S Mourtas, M Hammarlund-Udenaes… - Journal of controlled …, 2017 - Elsevier
… Liposomes were prepared as blank, α-M and transferrin-modified α-M, by thin-film hydration
method. Transferrin was covalently linked with α-M liposome through PEG linker and the …

[HTML][HTML] Microdialysis as an important technique in systems pharmacology—a historical and methodological review

M Hammarlund-Udenaes - The AAPS journal, 2017 - Springer
Microdialysis has contributed with very important knowledge to the understanding of target-specific
concentrations and their relationship to pharmacodynamic effects from a systems …

A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial

…, H Garmo, M Hammarlund-Udenaes… - Archives of internal …, 2009 - jamanetwork.com
Background Patients 80 years or older are underrepresented in scientific studies. The
objective of this study was to investigate the effectiveness of interventions performed by ward-…

AAPS-FDA workshop white paper: microdialysis principles, application and regulatory perspectives

…, H Derendorf, WF Elmquist, M Hammarlund-Udenaes… - 2007 - Springer
Many decisions in drug development and medical practice are based on measuring blood
concentrations of endogenous and exogenous molecules. Yet most biochemical and …

Species differences in blood-brain barrier transport of three positron emission tomography radioligands with emphasis on P-glycoprotein transport

…, GM Knudsen, M Hammarlund-Udenaes - Drug metabolism and …, 2009 - ASPET
Species differences occur in the brain concentrations of drugs, but the reasons for these
differences are not yet apparent. This study was designed to compare brain uptake of three …

Structure− brain exposure relationships in rat and human using a novel data set of unbound drug concentrations in brain interstitial and cerebrospinal fluids

…, M Hammarlund-Udenaes, M Antonsson - Journal of medicinal …, 2009 - ACS Publications
New experimental methodologies were applied to measure the unbound brain-to-plasma
concentration ratio (K p,uu,brain ) and the unbound CSF-to-plasma concentration ratio (K p,uu,…

The role of P‐glycoprotein in blood‐brain barrier transport of morphine: transcortical microdialysis studies in mdr1a (−/−) and mdr1a (+/+) mice

R Xie, M HammarlundUdenaes… - British journal of …, 1999 - Wiley Online Library
The aim of this study was to investigate whether blood‐brain barrier transport of morphine
was affected by the absence of mdr1a‐encoded P‐glycoprotein (Pgp), by comparing mdr1a (−/…

In vitro methods for estimating unbound drug concentrations in the brain interstitial and intracellular fluids

…, U Bredberg, M Hammarlund-Udenaes - Drug metabolism and …, 2007 - ASPET
Concentrations of unbound drug in the interstitial fluid of the brain are not rapidly measured
in vivo. Therefore, measurement of total drug levels, ie, the amount of drug per gram of brain, …

In vivo blood-brain barrier transport of oxycodone in the rat: indications for active influx and implications for pharmacokinetics/pharmacodynamics

…, USH Simonsson, M Hammarlund-Udenaes - Drug metabolism and …, 2006 - ASPET
… The transition modes for oxycodone, oxycodone-D3, and oxycodone-D6 were set to m/z
316.1 to m/z 297.9, m/z 319.1 to m/z 301, and m/z 322.2 to m/z 304, respectively. Mass …